Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Rzyman

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Cancers|June 2, 2021
Serum Metabolite Profiles in Participants of Lung Cancer Screening Study; Comparison of Two Independent CohortsPiotr Widłak, Karol Jelonek, Agata Kurczyk, et al.
Biomarker Research|May 16, 2025
A plasma 9-microRNA signature for lung cancer early detection: a multicenter analysisElisa Dama, Tommaso Colangelo, Roberto Cuttano, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2017
Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in EuropeJesper Holst Pedersen, Witold Rzyman, Giulia Veronesi, et al.
Cancers|July 24, 2021
The Lipid Composition of Serum-Derived Small Extracellular Vesicles in Participants of a Lung Cancer Screening StudyMateusz Smolarz, Agata Kurczyk, Karol Jelonek, et al.
Acta Biochimica Polonica|August 14, 2017
Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot studyMałgorzata Roś-Mazurczyk, Anna Wojakowska, Łukasz Marczak, et al.
Lung Cancer (Amsterdam, Netherlands)|February 10, 2009
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancerDorota Dworakowska, Ewa Jassem, Jacek Jassem, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 17, 2019
Increased plasma concentration of 4-pyridone-3-carboxamide-1-ß-D-ribonucleoside (4PYR) in lung cancer. Preliminary studiesPatrycja Jablonska, Paulina Mierzejewska, Barbara Kutryb-Zajac, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2023
miR-122 and miR-21 are Stable Components of miRNA Signatures of Early Lung Cancer after Validation in Three Independent CohortsJoanna Zyla, Rafal Dziadziuszko, Michal Marczyk, et al.
Pneumonologia I Alergologia Polska|September 23, 2006
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]Amelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Serum lipid profile discriminates patients with early lung cancer from healthy controlsMałgorzata Ros-Mazurczyk, Karol Jelonek, Michał Marczyk, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Cancers|June 2, 2021
Serum Metabolite Profiles in Participants of Lung Cancer Screening Study; Comparison of Two Independent CohortsPiotr Widłak, Karol Jelonek, Agata Kurczyk, et al.
Biomarker Research|May 16, 2025
A plasma 9-microRNA signature for lung cancer early detection: a multicenter analysisElisa Dama, Tommaso Colangelo, Roberto Cuttano, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2017
Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in EuropeJesper Holst Pedersen, Witold Rzyman, Giulia Veronesi, et al.
Cancers|July 24, 2021
The Lipid Composition of Serum-Derived Small Extracellular Vesicles in Participants of a Lung Cancer Screening StudyMateusz Smolarz, Agata Kurczyk, Karol Jelonek, et al.
Acta Biochimica Polonica|August 14, 2017
Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot studyMałgorzata Roś-Mazurczyk, Anna Wojakowska, Łukasz Marczak, et al.
Lung Cancer (Amsterdam, Netherlands)|February 10, 2009
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancerDorota Dworakowska, Ewa Jassem, Jacek Jassem, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 17, 2019
Increased plasma concentration of 4-pyridone-3-carboxamide-1-ß-D-ribonucleoside (4PYR) in lung cancer. Preliminary studiesPatrycja Jablonska, Paulina Mierzejewska, Barbara Kutryb-Zajac, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2023
miR-122 and miR-21 are Stable Components of miRNA Signatures of Early Lung Cancer after Validation in Three Independent CohortsJoanna Zyla, Rafal Dziadziuszko, Michal Marczyk, et al.
Pneumonologia I Alergologia Polska|September 23, 2006
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]Amelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Serum lipid profile discriminates patients with early lung cancer from healthy controlsMałgorzata Ros-Mazurczyk, Karol Jelonek, Michał Marczyk, et al.
Pageof 8